Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | MYL3 |
| Upstream (Parents) |
|---|
| (<<) ATP7B → MYL3 |
| (<<) CREB3L1 → MYL3 |
| (<<) DDX21 → MYL3 |
| (<<) EIF2AK2 → MYL3 |
| (<<) ENC1 → MYL3 |
| (<<) KCTD12 → MYL3 |
| (<<) MAP3K7 → MYL3 |
| (<<) MAP3K9 → MYL3 |
| (<<) MRAS → MYL3 |
| (<<) PLD3 → MYL3 |
| (<<) SALL2 → MYL3 |
| (<<) SLC26A1 → MYL3 |
| (<<) SPPL2B → MYL3 |
| (<<) TMPRSS11D → MYL3 |
| (<<) TP53 → MYL3 |
| (<<) TYK2 → MYL3 |
| Downstream (Children) |
|---|
| MYL3 → CBS (>>) |
| MYL3 → CHODL (>>) |
| MYL3 → CLCA4 (>>) |
| MYL3 → CTRB2 (>>) |
| MYL3 → CYP1A1 (>>) |
| MYL3 → FGFBP1 (>>) |
| MYL3 → LRP6 (>>) |
| MYL3 → MYCN (>>) |
| MYL3 → OVOL1 (>>) |
| MYL3 → PLCB4 (>>) |
